Jorge A. Garcia
Dr. Jorge A. Garcia is a genitourinary medical oncologist and chair of the Solid Tumor Oncology Division at University Hospitals Seidman Cancer Center and Case Western Reserve University in Cleveland, Ohio. He is recognized for his contributions to precision oncology and has been involved in advancing treatment options for prostate cancer, particularly in relation to new therapies like the recently FDA-approved Pluvicto, aimed at improving outcomes for patients with metastatic castration-resistant prostate cancer (mCRPC).
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 8.00 | 0.02% | +0% | 331,002,651 | 73,458 | $21,000,000 | 4,660$ |
| Totals | 1 | 331,002,651 | 73,458 | $21,000,000 | 4,660$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Jorge A. Garcia, MD, a genitourinary medical oncologist, highlights the transformative step forward in the treatment of mCRPC.
8